About Solarea Bio
Solarea Bio is a company based in Cambridge (United States) founded in 2017 by Gerardo V Toledo.. Solarea Bio has raised $37.24 million across 5 funding rounds from investors including Illumina, GISEV and S2G Ventures. Solarea Bio offers products and services including SBD111, SBD121, SBD3, SBD4, and Bondia. Solarea Bio operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Cambridge, United States
- Founders Gerardo V Toledo
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Solarea Bio, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$37.24 M (USD)
in 5 rounds
-
Latest Funding Round
$9.91 M (USD), Series A
Nov 04, 2025
-
Investors
Illumina
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Solarea Bio
Solarea Bio offers a comprehensive portfolio of products and services, including SBD111, SBD121, SBD3, SBD4, and Bondia. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Clinically validated to slow bone loss in humans.
Developed for dietary needs in rheumatoid arthritis patients.
Targets dietary requirements for psoriatic arthritis management.
Addresses cellular aging through microbial innovations.
Beta launch for microbial solutions in health applications.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Solarea Bio
Solarea Bio has successfully raised a total of $37.24M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $9.91 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $9.9M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series A - Solarea Bio | Valuation |
investors |
|
| Aug, 2024 | Amount | Series B - Solarea Bio | Valuation |
investors |
|
| May, 2023 | Amount | Series B - Solarea Bio | Valuation | S2G Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Solarea Bio
Solarea Bio has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, GISEV and S2G Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage agnostic venture capital firm
|
Founded Year | Domain | Location | |
|
Early-stage life sciences and tech focused VC firm investing primarily in the US
|
Founded Year | Domain | Location | |
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Solarea Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Solarea Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Solarea Bio Comparisons
Competitors of Solarea Bio
Solarea Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Solarea Bio
Frequently Asked Questions about Solarea Bio
When was Solarea Bio founded?
Solarea Bio was founded in 2017.
Where is Solarea Bio located?
Solarea Bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Solarea Bio?
Gerardo V Toledo is the current CEO of Solarea Bio. They have also founded this company.
Is Solarea Bio a funded company?
Solarea Bio is a funded company, having raised a total of $37.24M across 5 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Jul 26, 2017.
What does Solarea Bio do?
Solarea Bio was founded in 2017 and is based in Cambridge, United States. Therapeutics based on the microbiome are developed, with probiotics sourced from natural origins. Services encompassing microbial genomics, metagenomics, and genome-wide metabolic models are provided to validate potential candidates. Operations are centered in the biotechnology sector, targeting health-related applications through microbial research.
Who are the top competitors of Solarea Bio?
Solarea Bio's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Solarea Bio offer?
Solarea Bio offers SBD111, SBD121, SBD3, SBD4, and Bondia.
Who are Solarea Bio's investors?
Solarea Bio has 6 investors. Key investors include Illumina, GISEV, S2G Ventures, Bold Capital Partners, and Viking Global Investors.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.